HOME
COMPANY
PROFILO
MISSION & VALORI
PRESENZA INTERNAZIONALE
MANUFACTURING
COMMITMENT
QUALITÀ
SOUND MEDS
ESG POLICY
RESPONSABILITÀ SOCIALE D’IMPRESA
SIFI FOR AK AWARENESS
EYE DISORDERS
EYE INFECTIONS & INFLAMMATIONS
CATARACT AND REFRACTIVE PROBLEMS
GLAUCOMA
OCULAR SURFACE DISORDERS
RETINAL DISORDERS
VITREOUS DISORDERS
R&D
MEDIA
COMUNICATI STAMPA
CONTATTI
COUNTRY SITES
ITALY
FRANCE
SPAIN
MEXICO
ROMANIA
TURKEY
COUNTRY SITES
ITALY
FRANCE
SPAIN
MEXICO
ROMANIA
TURKEY
Medical Professionals
Early Access Programs
Contatti
Media
Comunicati Stampa
R&D
Eye Disorders
Eye infections & inflammations
Cataract and refractive problems
Glaucoma
Ocular surface disorders
Retinal disorders
Vitreous disorders
Commitment
Qualità
Sound Meds
ESG Policy
RESPONSABILITÀ SOCIALE D’IMPRESA
SIFI FOR AK AWARENESS
Company
Profilo
Mission & Valori
Presenza Internazionale
Manufacturing
Media > Comunicati Stampa
>
Comunicati Stampa
<<
1
2
3
4
5
6
7
8
>>
SIFI Announces Positive Topline Results of the Pivotal Phase III Study of Polihexanide for the Treatment of Acanthamoeba Keratitis
13 Ottobre 2021
SIFI ANNOUNCES POSITIVE TOPLINE RESULTS OF THE PIVOTAL PHASE III STUDY OF POLIHEXANIDE FOR THE TREATMENT OF ACANTHAMOEBA KERATITIS • Polihexanide 0,08% monotherapy met the primary endpoint of clinical resolution rate over a ...
> leggi
SIFI AND RADICEPURA BOTANICAL PARK TO BACK A BID TO CREATE AN ENVIRONMENTALLY FRIENDLY, HIGH-SOCIAL IMPACT GREEN AREA.
13 Settembre 2021
“Keep Alive the Sense of Wonder” Call for Ideas opens today, to plan a green area and an educational park on the SIFI and Aci Sant’Antonio premises. Catania, 13th Sept. - SIFI SpA, a leading ophthalmic pharmaceutical company, in ...
> leggi
SIFI to Present at BIO Digital International Convention 2021
09 Giugno 2021
Media Contacts Sabrina Zappia Catania (Italy) – 9 June 2021 – SIFI, a leading international ophthalmic company focused on the development and commercialization of innovative therapeutic solutions for patients with ophthalmic condition...
> leggi
SIFI and Bausch Health Russia Announce Strategic Commercial Partnership that Will Ensure Greater Access to Important Eye Care Medicines in Russia
17 Maggio 2021
SIFI expands its presence in eastern Europe and northern Asia entering into a multi-year commercial agreement with Bausch Health Russia Catania, Italy - May 17, 2021 – SIFI, a leading international ophthalmic company, announces it has entere...
> leggi
SIFI Initiates Patient Enrollment in Phase II Trial evaluating Pro-ocular in Dry Eye Disease
27 Aprile 2021
ProGIFT is a 3 arms, multicenter, randomized, double-masked clinical trial in Italy. Catania (Italy) - 27 April 2021 - SIFI announced today the enrollment of the first patients in the ProGIFT trial (NCT04645446), which aims at evaluating the safet...
> leggi
<<
1
2
3
4
5
6
7
8
>>
Per le attività relative a Press & Communication prego contattare:
CITYnet communication
Rome, ITALY
press@sifigroup.com
Visita i nostri social channel!
Comunicati Stampa
Per le attività relative a Press & Communication prego contattare: CITYnet communication Rome, ITALY press@sifigroup.com Visita i nostri social channel!
Tweets by sifigroup
SIFI SpA
Site Map
Disclaimer
Privacy & Cookies Policy
Condizioni d'uso
© Copyright 2020 SIFI S.p.A - Tutti i diritti riservati - P.Iva 00122890874
Follow Us!
